Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
89.16 CHF | -0.39% | +2.20% | +5.20% |
12:32pm | Morphosys says takeover by Novartis on course after report of drug safety concern | RE |
04-26 | NOVARTIS AG : Receives a Buy rating from Jefferies | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.20% | 200B | |
+26.84% | 661B | |
+27.35% | 566B | |
-6.35% | 352B | |
+20.44% | 332B | |
+2.65% | 283B | |
+13.94% | 231B | |
-9.04% | 195B | |
-4.79% | 145B | |
-10.52% | 144B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Zacks Lifts Price Target on Novartis, Maintains Neutral Recommendation